[Corneal crosslinking: "Safe and effective"?].
Cursiefen
C
C
D000328:Adult; D003094:Collagen / Q000187:drug effects*; D003131:Combined Modality Therapy; D003432:Cross-Linking Reagents / Q000627:therapeutic use; D005858:Germany; D006801:Humans; D007640:Keratoconus / Q000150:complications* / Q000188:drug therapy*; D008137:Longitudinal Studies; D008297:Male; D010778:Photochemotherapy / Q000379:methods; D017319:Photosensitizing Agents / Q000008:administration & dosage; D012189:Retrospective Studies; D012256:Riboflavin / Q000008:administration & dosage*; D016896:Treatment Outcome; D014467:Ultraviolet Therapy / Q000379:methods*; D014786:Vision Disorders / Q000209:etiology* / Q000517:prevention & control*
D003432:Cross-Linking Reagents; D017319:Photosensitizing Agents; D003094:Collagen; D012256:Riboflavin